Cargando…

Pharmacological Properties of Trichostatin A, Focusing on the Anticancer Potential: A Comprehensive Review

Trichostatin A (TSA), a natural derivative of dienohydroxamic acid derived from a fungal metabolite, exhibits various biological activities. It exerts antidiabetic activity and reverses high glucose levels caused by the downregulation of brain-derived neurotrophic factor (BDNF) expression in Schwann...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouyahya, Abdelhakim, El Omari, Nasreddine, Bakha, Mohamed, Aanniz, Tarik, El Menyiy, Naoual, El Hachlafi, Naoufal, El Baaboua, Aicha, El-Shazly, Mohamed, Alshahrani, Mohammed Merae, Al Awadh, Ahmed Abdullah, Lee, Learn-Han, Benali, Taoufiq, Mubarak, Mohammad S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612318/
https://www.ncbi.nlm.nih.gov/pubmed/36297347
http://dx.doi.org/10.3390/ph15101235
_version_ 1784819745211547648
author Bouyahya, Abdelhakim
El Omari, Nasreddine
Bakha, Mohamed
Aanniz, Tarik
El Menyiy, Naoual
El Hachlafi, Naoufal
El Baaboua, Aicha
El-Shazly, Mohamed
Alshahrani, Mohammed Merae
Al Awadh, Ahmed Abdullah
Lee, Learn-Han
Benali, Taoufiq
Mubarak, Mohammad S.
author_facet Bouyahya, Abdelhakim
El Omari, Nasreddine
Bakha, Mohamed
Aanniz, Tarik
El Menyiy, Naoual
El Hachlafi, Naoufal
El Baaboua, Aicha
El-Shazly, Mohamed
Alshahrani, Mohammed Merae
Al Awadh, Ahmed Abdullah
Lee, Learn-Han
Benali, Taoufiq
Mubarak, Mohammad S.
author_sort Bouyahya, Abdelhakim
collection PubMed
description Trichostatin A (TSA), a natural derivative of dienohydroxamic acid derived from a fungal metabolite, exhibits various biological activities. It exerts antidiabetic activity and reverses high glucose levels caused by the downregulation of brain-derived neurotrophic factor (BDNF) expression in Schwann cells, anti-inflammatory activity by suppressing the expression of various cytokines, and significant antioxidant activity by suppressing oxidative stress through multiple mechanisms. Most importantly, TSA exhibits potent inhibitory activity against different types of cancer through different pathways. The anticancer activity of TSA appeared in many in vitro and in vivo investigations that involved various cell lines and animal models. Indeed, TSA exhibits anticancer properties alone or in combination with other drugs used in chemotherapy. It induces sensitivity of some human cancers toward chemotherapeutical drugs. TSA also exhibits its action on epigenetic modulators involved in cell transformation, and therefore it is considered an epidrug candidate for cancer therapy. Accordingly, this work presents a comprehensive review of the most recent developments in utilizing this natural compound for the prevention, management, and treatment of various diseases, including cancer, along with the multiple mechanisms of action. In addition, this review summarizes the most recent and relevant literature that deals with the use of TSA as a therapeutic agent against various diseases, emphasizing its anticancer potential and the anticancer molecular mechanisms. Moreover, TSA has not been involved in toxicological effects on normal cells. Furthermore, this work highlights the potential utilization of TSA as a complementary or alternative medicine for preventing and treating cancer, alone or in combination with other anticancer drugs.
format Online
Article
Text
id pubmed-9612318
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96123182022-10-28 Pharmacological Properties of Trichostatin A, Focusing on the Anticancer Potential: A Comprehensive Review Bouyahya, Abdelhakim El Omari, Nasreddine Bakha, Mohamed Aanniz, Tarik El Menyiy, Naoual El Hachlafi, Naoufal El Baaboua, Aicha El-Shazly, Mohamed Alshahrani, Mohammed Merae Al Awadh, Ahmed Abdullah Lee, Learn-Han Benali, Taoufiq Mubarak, Mohammad S. Pharmaceuticals (Basel) Review Trichostatin A (TSA), a natural derivative of dienohydroxamic acid derived from a fungal metabolite, exhibits various biological activities. It exerts antidiabetic activity and reverses high glucose levels caused by the downregulation of brain-derived neurotrophic factor (BDNF) expression in Schwann cells, anti-inflammatory activity by suppressing the expression of various cytokines, and significant antioxidant activity by suppressing oxidative stress through multiple mechanisms. Most importantly, TSA exhibits potent inhibitory activity against different types of cancer through different pathways. The anticancer activity of TSA appeared in many in vitro and in vivo investigations that involved various cell lines and animal models. Indeed, TSA exhibits anticancer properties alone or in combination with other drugs used in chemotherapy. It induces sensitivity of some human cancers toward chemotherapeutical drugs. TSA also exhibits its action on epigenetic modulators involved in cell transformation, and therefore it is considered an epidrug candidate for cancer therapy. Accordingly, this work presents a comprehensive review of the most recent developments in utilizing this natural compound for the prevention, management, and treatment of various diseases, including cancer, along with the multiple mechanisms of action. In addition, this review summarizes the most recent and relevant literature that deals with the use of TSA as a therapeutic agent against various diseases, emphasizing its anticancer potential and the anticancer molecular mechanisms. Moreover, TSA has not been involved in toxicological effects on normal cells. Furthermore, this work highlights the potential utilization of TSA as a complementary or alternative medicine for preventing and treating cancer, alone or in combination with other anticancer drugs. MDPI 2022-10-08 /pmc/articles/PMC9612318/ /pubmed/36297347 http://dx.doi.org/10.3390/ph15101235 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Bouyahya, Abdelhakim
El Omari, Nasreddine
Bakha, Mohamed
Aanniz, Tarik
El Menyiy, Naoual
El Hachlafi, Naoufal
El Baaboua, Aicha
El-Shazly, Mohamed
Alshahrani, Mohammed Merae
Al Awadh, Ahmed Abdullah
Lee, Learn-Han
Benali, Taoufiq
Mubarak, Mohammad S.
Pharmacological Properties of Trichostatin A, Focusing on the Anticancer Potential: A Comprehensive Review
title Pharmacological Properties of Trichostatin A, Focusing on the Anticancer Potential: A Comprehensive Review
title_full Pharmacological Properties of Trichostatin A, Focusing on the Anticancer Potential: A Comprehensive Review
title_fullStr Pharmacological Properties of Trichostatin A, Focusing on the Anticancer Potential: A Comprehensive Review
title_full_unstemmed Pharmacological Properties of Trichostatin A, Focusing on the Anticancer Potential: A Comprehensive Review
title_short Pharmacological Properties of Trichostatin A, Focusing on the Anticancer Potential: A Comprehensive Review
title_sort pharmacological properties of trichostatin a, focusing on the anticancer potential: a comprehensive review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612318/
https://www.ncbi.nlm.nih.gov/pubmed/36297347
http://dx.doi.org/10.3390/ph15101235
work_keys_str_mv AT bouyahyaabdelhakim pharmacologicalpropertiesoftrichostatinafocusingontheanticancerpotentialacomprehensivereview
AT elomarinasreddine pharmacologicalpropertiesoftrichostatinafocusingontheanticancerpotentialacomprehensivereview
AT bakhamohamed pharmacologicalpropertiesoftrichostatinafocusingontheanticancerpotentialacomprehensivereview
AT aanniztarik pharmacologicalpropertiesoftrichostatinafocusingontheanticancerpotentialacomprehensivereview
AT elmenyiynaoual pharmacologicalpropertiesoftrichostatinafocusingontheanticancerpotentialacomprehensivereview
AT elhachlafinaoufal pharmacologicalpropertiesoftrichostatinafocusingontheanticancerpotentialacomprehensivereview
AT elbaabouaaicha pharmacologicalpropertiesoftrichostatinafocusingontheanticancerpotentialacomprehensivereview
AT elshazlymohamed pharmacologicalpropertiesoftrichostatinafocusingontheanticancerpotentialacomprehensivereview
AT alshahranimohammedmerae pharmacologicalpropertiesoftrichostatinafocusingontheanticancerpotentialacomprehensivereview
AT alawadhahmedabdullah pharmacologicalpropertiesoftrichostatinafocusingontheanticancerpotentialacomprehensivereview
AT leelearnhan pharmacologicalpropertiesoftrichostatinafocusingontheanticancerpotentialacomprehensivereview
AT benalitaoufiq pharmacologicalpropertiesoftrichostatinafocusingontheanticancerpotentialacomprehensivereview
AT mubarakmohammads pharmacologicalpropertiesoftrichostatinafocusingontheanticancerpotentialacomprehensivereview